Gene · 8794
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2023 | 36902340 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications. | Int J Mol Sci | 2023 | 36902036 | PubTator, text mining | PubMed |
| Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development. | Cell Death Dis | 2023 | 36899018 | PubTator, text mining | PubMed |
| HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. | PLoS Pathog | 2023 | 36867660 | PubTator, text mining | PubMed |
| RNA sequencing-based transcriptome analysis of granulosa cells from follicular fluid: Genes involved in embryo quality during in vitro fertilization and embryo transfer. | PLoS One | 2023 | 36857405 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress. | Vaccines (Basel) | 2023 | 36851096 | PubTator, text mining | PubMed |
| Santin (5,7-Dihydroxy-3,6,4'-Trimetoxy-Flavone) Enhances TRAIL-Mediated Apoptosis in Colon Cancer Cells. | Life (Basel) | 2023 | 36836951 | PubTator, text mining | PubMed |
| Quantitative Proteomic Characterization of Foreign Body Response towards Silicone Breast Implants Identifies Chronological Disease-Relevant Biomarker Dynamics. | Biomolecules | 2023 | 36830674 | PubTator, text mining | PubMed |
A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy-Application to Nonsense Suppressor Screening and Mechanistic Studies. | Biomolecules | 2023 | 36830611 | PubTator, text mining | PubMed |
| HIF-1α participates in secondary brain injury through regulating neuroinflammation. | Transl Neurosci | 2023 | 36815939 | PubTator, text mining | PubMed |
| Past and present: a bibliometric study on polycystic ovary syndrome. | J Ovarian Res | 2023 | 36803912 | PubTator, text mining | PubMed |
| DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL. | J Clin Med | 2023 | 36675536 | PubTator, text mining | PubMed |
| Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer. | Sci Rep | 2023 | 36646765 | PubTator, text mining | PubMed |
| Therapeutic targeting of TRAIL death receptors. | Biochem Soc Trans | 2023 | 36629496 | PubTator, text mining | PubMed |
| Highly concentrated trehalose induces prohealing senescence-like state in fibroblasts via CDKN1A/p21. | Commun Biol | 2023 | 36609486 | PubTator, text mining | PubMed |
| The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification). | BMC Cancer | 2023 | 36609243 | PubTator, text mining | PubMed |
| DPP3 expression promotes cell proliferation and migration in vitro and tumour growth in vivo, which is associated with poor prognosis of oesophageal carcinoma. | Oncol Rep | 2023 | 36382663 | PubTator, text mining | PubMed |
| Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells. | J Exp Med | 2023 | 36305874 | PubTator, text mining | PubMed |
| Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries. | Cell Death Differ | 2023 | 36195672 | PubTator, text mining | PubMed |
| Trafficking protein TMED3 promotes esophageal squamous cell carcinoma. | Biomed J | 2023 | 35358714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8794/papers?page=9